Charles Schwab Investment Management Inc Dynavax Technologies Corp Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,137,573 shares of DVAX stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,137,573
Previous 1,078,871
5.44%
Holding current value
$12.5 Million
Previous $13.4 Million
4.59%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding DVAX
# of Institutions
259Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$241 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$120 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$87.6 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$78.6 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.39B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...